Long-COVID vs. POTS: Characterization of the Patient Experience

Summary

Long-COVID is a condition marked by the continuation of COVID-19 symptoms—or the emergence of new ones—after recovery from acute (or the initial phase of illness of) COVID-19. While there is not yet a formal definition of long COVID, it generally refers to the persistence of symptoms four weeks or longer after the onset of COVID-19. Long-COVID has many similarities to disorders of the autonomic nervous system, such as postural orthostatic tachycardia syndrome (POTS).

In this study we are trying to understand the quality of life of Long-COVID and POTS patients.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 80

Inclusion criteria:

• Patients with Long-COVID:
o Long-COVID symptoms for at least 3 months after COVID infection

• Patients with POTS
o Physician Diagnosis of POTS as defined by the CCS Consensus Statement1 and as follows:
 Sustained, excessive orthostatic tachycardia ≥ 30 bpm within 10 minutes standing.
 Absence of orthostatic hypotension (>20/10 mmHg decrease) within 3 minutes standing

• Canadian resident
• Age 18-80 years
• Male and female
• Able and willing to provide informed consent

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

Rashmin Hira

Principal investigator:

Satish Raj

Clinical trial:

No

REB-ID:

REB22-0724